Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

499.99
Delayed Data
As of Sep 04
 -8.52 / -1.68%
Today’s Change
320.06
Today|||52-Week Range
605.93
+21.87%
Year-to-Date

Today’s Trading

Previous close508.51
Today’s open500.51
Day’s range498.98 - 507.97
Volume806,805
Average volume (3 months)753,363
Market cap$52.7B
Dividend yield--
Data as of 4:14pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+21.79%
Earnings growth (next 5 years)+28.02%
Revenue growth (last year)+33.96%
P/E ratio125.9
Price/Sales16.50
Price/Book20.49

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-1.56-2.10%
ALNYAlnylam Pharmaceutic...+0.55+0.57%
ISISIsis Pharmaceuticals...+0.53+1.03%
ICLRICON PLC+0.12+0.16%
Data as of 4:01pm ET, 09/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$3.10
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers